Biosota Supports Women’s Health Initiative Amidst Emerging Cancer Research on High-MGO Manuka Honey

Gold Coast, Australia, 31 March 2026 - Growing global awareness around women’s health is driving both community action and scientific exploration, with Australian Manuka honey producer Biosota Organics contributing to both through a recent international fundraising initiative and ongoing education around high-MGO Manuka honey.

In March, Biosota raised US$1,060 in support of the Australia-based Mater Foundation, with contributions from customers across United States and Australia. Funds raised contribute to research, care and support services for women and families, particularly those affected by breast cancer.

Alongside customer participation, the Biosota team took part in the “5K Your Way” community walk in Australia, supporting Mater Chicks in Pink, a programme that provides personalised support services for women undergoing breast cancer treatment (1, 2). The walk forms part of the broader Mater International Women’s Day Fun Run, which saw more than 23,000 participants raise over $2 million in 2026.

“Women’s health is a shared global priority,” said Biosota founder Andrey Zubko. “What we’re seeing is a growing alignment between community-led initiatives and scientific interest in natural compounds that may support wellbeing. It’s encouraging to see this conversation expanding internationally.”

Understanding Manuka Honey and MGO Strength

Manuka honey is derived from a medicinal plant native only to Australia and New Zealand and has long been valued for its unique bioactive properties. In particular, medical-grade Manuka honey has been widely studied for its role in wound care, immune support and skin health, with findings supported by peer-reviewed research.

A key measure of Manuka honey’s potency is methylglyoxal (MGO), a naturally occurring compound responsible for its strength. Higher MGO levels indicate greater concentration, which correlates with increased potency, value and application.

Research Interest Expands in Breast Cancer Models

Scientific attention has increasingly focused on high-MGO Manuka honey, particularly in preclinical cancer research. Recent studies (2024–2025), including those referenced by UCLA Health, have explored its effects in breast cancer models.

Findings suggest Manuka honey may influence tumour growth and support apoptosis, or programmed cancer cell death. One study reported up to an 84% reduction in tumour growth in mice with estrogen receptor-positive (ER+) breast cancer. Additional laboratory findings indicate potential effects on key biological pathways (AMPK/AKT/mTOR) and inflammatory responses.

While these findings are early and limited to laboratory and animal models, they are contributing to growing global interest in Manuka honey as a complementary area of research.

“High-MGO Manuka honey is increasingly recognised as a natural functional food with unique bioactive properties,” Zubko added. “At the same time, it’s essential to be clear that it is not a treatment or substitute for medical care.”

References

1. Mater Foundation. 5K Your Way – Mater International Women’s Day Fun Run 2026.
   Link https://fundraise.mater.org.au/event/funrun-2026/5kyw
2. Mater Foundation. Mater Chicks in Pink – Supporting women with breast cancer.
   Link: https://www.materfoundation.org.au/what-we-do/mater-chicks-in-pink